Transporter Interaction Screening
Transporter Interaction Screening is a systematic methodological framework within pharmacological and biomedical research that identifies and characterizes molecular interactions between bioactive compounds and membrane transporters to evaluate potential drug disposition, efficacy, and toxicity profiles.
21
Publications
904
Citations
139
Authors
43
Institutions
Publications per year
2017–2026
6
Parents
21
Hikaru Saito, Hiroyuki Hirano, Hiroshi Nakagawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 92 citations
Hiroyuki Hirano, Atsuo Kurata, Yuko Onishi et al. · Molecular Pharmaceutics · 2006 · 55 citations
1–5 of 21
139
2
h-index
2
h-index
University of California, San Francisco, United States
2 publications · 190 citations
2
h-index
2
h-index
2
h-index
1–5 of 139
43
University of California, San Francisco
San Francisco, United States
2 h-index
7 publications
591 citations
National Institutes of Health
Bethesda, United States
2 h-index
3 publications
111 citations
Tokyo Institute of Technology
Tokyo, Japan
2 h-index
12 publications
697 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
1 h-index
1 publications
21 citations
University of Bari Aldo Moro
Bari, Italy
1 h-index
10 publications
280 citations
Xiangya Hospital Central South University
Changsha, China
1 h-index
2 publications
46 citations

Hungarian Academy of Sciences
Budapest, Hungary
1 h-index
6 publications
252 citations
Pharmo Institute
Utrecht, Netherlands
1 h-index
1 publications
93 citations
1–8 of 43
2 publications · 69 citations
2
h-index
2 publications · 40 citations
2
h-index
2 publications · 98 citations
2
h-index
1 publications · 23 citations
1
h-index
RCM · 1 publications · 30 citations
1
h-index
1–5